151 related articles for article (PubMed ID: 27517343)
1. Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males.
Karanikas E; Griveas I; Ntouros E; Floros G; Garyfallos G
Psychiatry Res; 2016 Oct; 244():333-8. PubMed ID: 27517343
[TBL] [Abstract][Full Text] [Related]
2. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
3. Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-α, IFN-γ, ΤNF-β, IL-4 deviation.
Karanikas E; Manganaris S; Ntouros E; Floros G; Antoniadis D; Garyfallos G
Asian J Psychiatr; 2017 Apr; 26():99-103. PubMed ID: 28483103
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.
Carol EE; Spencer RL; Mittal VA
Psychoneuroendocrinology; 2016 Oct; 72():87-93. PubMed ID: 27388688
[TBL] [Abstract][Full Text] [Related]
5. [Stress and psychotic transition: A literature review].
Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis.
Labad J; Armario A; Nadal R; Solé M; Gutiérrez-Zotes A; Montalvo I; Moreno-Samaniego L; Martorell L; Sánchez-Gistau V; Vilella E
Psychiatry Res; 2018 Jul; 265():284-291. PubMed ID: 29775885
[TBL] [Abstract][Full Text] [Related]
7. Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis.
Pruessner M; Bechard-Evans L; Pira S; Joober R; Collins DL; Pruessner JC; Malla AK
Psychol Med; 2017 Feb; 47(3):471-483. PubMed ID: 27774914
[TBL] [Abstract][Full Text] [Related]
8. Biological stress response in women at risk of postpartum psychosis: The role of life events and inflammation.
Aas M; Vecchio C; Pauls A; Mehta M; Williams S; Hazelgrove K; Biaggi A; Pawlby S; Conroy S; Seneviratne G; Mondelli V; Pariante CM; Dazzan P
Psychoneuroendocrinology; 2020 Mar; 113():104558. PubMed ID: 31923613
[TBL] [Abstract][Full Text] [Related]
9. Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.
Zeni-Graiff M; Rizzo LB; Mansur RB; Maurya PK; Sethi S; Cunha GR; Asevedo E; Pan P; Zugman A; Yamagata AS; Higuchi C; Bressan RA; Gadelha A; Brietzke E
Schizophr Res; 2016 Oct; 176(2-3):191-195. PubMed ID: 27424266
[TBL] [Abstract][Full Text] [Related]
10. [Study on the correlation between the inflammatory factors in the serum and the induced sputum and the hypothalamic-pituitary-adrenal axis function in advanced lung adenocarcinoma of different syndromes].
Du YJ; Cao YX; Duan XH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jul; 32(7):896-901. PubMed ID: 23019942
[TBL] [Abstract][Full Text] [Related]
11. Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
Nordholm D; Rostrup E; Mondelli V; Randers L; Nielsen MØ; Wulff S; Nørbak-Emig H; Broberg BV; Krakauer K; Dazzan P; Zunszain PA; Nordentoft M; Glenthøj B
Psychoneuroendocrinology; 2018 Jun; 92():72-80. PubMed ID: 29635174
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of endotoxin in a rat model of chronic inflammation are accompanied by suppressed secretion of pro-inflammatory cytokines and biphasic alteration in hypothalamo-pituitary-adrenal axis activity.
Richards LJ; Chover-Gonzalez A; Harbuz MS; Jessop DS
J Neuroendocrinol; 2006 Nov; 18(11):875-82. PubMed ID: 17026537
[TBL] [Abstract][Full Text] [Related]
13. Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort.
Ntouros E; Karanikas E; Floros G; Andreou C; Tsoura A; Garyfallos G; Bozikas VP
Cogn Neuropsychiatry; 2018 Mar; 23(2):103-115. PubMed ID: 29447074
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients.
Phassouliotis C; Garner BA; Phillips LJ; Bendall S; Yun Y; Markulev C; Kerr M; McGorry PD
Aust N Z J Psychiatry; 2013 Apr; 47(4):363-70. PubMed ID: 23172653
[TBL] [Abstract][Full Text] [Related]
15. Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with "at risk" mental state.
Aiello G; Horowitz M; Hepgul N; Pariante CM; Mondelli V
Psychoneuroendocrinology; 2012 Oct; 37(10):1600-13. PubMed ID: 22663896
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.
Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML
J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591
[TBL] [Abstract][Full Text] [Related]
17. Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders.
Carol EE; Mittal VA
Psychoneuroendocrinology; 2015 Jul; 57():26-36. PubMed ID: 25880698
[TBL] [Abstract][Full Text] [Related]
18. The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals.
Juncal-Ruiz M; Riesco-Dávila L; de la Foz VO; Ramírez-Bonilla M; Martínez-García O; Irure-Ventura J; Leza JC; López-Hoyos M; Crespo-Facorro B
J Neuroinflammation; 2018 Feb; 15(1):63. PubMed ID: 29490673
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced pro- and anti-inflammatory cytokine concentrations in panic disorder patients.
Petrowski K; Wichmann S; Kirschbaum C
Psychoneuroendocrinology; 2018 Aug; 94():31-37. PubMed ID: 29754003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
